Skip to main content

MFG · Mizuho Financial Group Inc · Metrics

Track MFG — free
$9.68 -0.15 (-1.53%) At close · Nov 18 Q2 2024 earnings call transcript
Market Cap
$116.87B
Shares
12.07B
Volume · Nov 18 4.86M Avg daily vol (3M) 3.71M

MFG metrics

57 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$9.68
Market cap
$116.87B

Price action

23 metrics
Price change (1W)
-4.7%
Price change (30D)
-3.9%
Price change (3M)
-4.5%
Price change (6M)
+7.0%
Price change (YTD)
+32.2%
Price change (1Y)
+47.8%
Trailing year
Price change (5Y)
+275.2%
52-week high
$11.45
52-week low
$6.45
Change from 52-week high
-15.5%
Change from 52-week low
+50.1%
Annualized volatility
33.6%
Annualized volatility (3M)
32.3%
Implied volatility (30D)
41.9%
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
1.3
RSI (14D)
43.2
Price vs SMA 50
-6.7%
Price vs SMA 200
+0.7%
Avg volume (3M)
3.71M
Relative volume
1.3
Average dollar volume
$38.42M

Company

3 metrics
Sector
Financial Services
Industry
Banks - Regional
Shares outstanding
12.07B

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
1.7
reciprocal yield 58.4%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
0.9%
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
$0.09
Dividend growth YoY
-53.9%
Dividend growth streak
1
Last ex-dividend
2026-03-31

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2023-09-30

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
13.2%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$8,723.13

Growth

11 metrics
Revenue growth YoY
+7.6%
Year over year
Net income growth YoY
+95.2%
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
+98.7%
Shares change YoY
-1.8%
Year over year · fewer shares
Revenue CAGR (3Y)
+27.2%
Revenue CAGR (5Y)
+20.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
+15.2%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
10.7%
Return on assets
0.4%
Debt / equity
—
Current ratio
—
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$393.55B
Total assets
$1.85T
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
499
13F filer change QoQ
+30
Institutional ownership
2.5%
Conviction holders (share of 13F filers)
0.4%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+12.6%
Holder tenure
19.9
Price vs estimated holder cost
+36.4%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
0.1%
Latest settlement · 2.2 days to cover
Days to cover
2.2d
Short-squeeze score
31 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1335730 CUSIP 60687Y109 13F (30d) 470 filings 427 filers Visit website Investor relations